Epocrates, Inc.  

(Public, NASDAQ:EPOC)   Watch this stock  
Find more results for EPOC
11.73
Real-time:   4:00PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 6.90 - 11.97
Open     -
Vol / Avg. 0.00/228,735.00
Mkt cap 291.75M
P/E     -
Div/yield     -
EPS -0.30
Shares     -
Beta     -
Inst. own     -

Key stats and ratios

Q3 (Sep '12) 2011
Net profit margin -3.90% -3.15%
Operating margin -4.35% -5.32%
EBITD margin - 2.39%
Return on average assets -2.79% -2.56%
Return on average equity -4.78% -14.85%
Employees 360 -
CDP Score - -

Address

Suite 300, 1100 Park Place
SAN MATEO, CA 94403
United States - Map
+1-650-2271700 (Phone)
+1-650-2272770 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Epocrates, Inc. is physician platform for clinical content, practice tools and health industry engagement at the point of care. As of December 31, 2012, the Company has one million healthcare professionals, including approximately 330,000 or more than 50% of the United States physicians. The Company�s application, mobile drug reference, provides point-of-care access to information such as dosing, drug interactions, pricing and insurance coverage for thousands of brand, generic and over-the-counter drugs. The Company offers its products on the United States mobile platforms including Apple iOS, Android and BlackBerry. The Company offers su